TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03853928 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03853928 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT01242007 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01091207 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01091207 — Predictive Biomarker (PRD): KIT
Genes: CD117; SCFR; C-Kit
Study NCT00767871 — Predictive Biomarker (PRD): PAG1 mRNA
Genes: PAG1; CBP; PAG
Study NCT02941003 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01621724 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT00058032 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT02607332 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01334515 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01334515 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00832806 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT03469804 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01674855 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01699828 — Safety Biomarker (SAF): DRD3
Study NCT00019721 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04984785 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT01018979 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01018979 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02278354 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00848185 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00848185 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study NCT00754780 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT03503097 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT04510415 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04510415 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03307954 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02635035 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT03543774 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04500652 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00005047 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06021379 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01374217 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT02595840 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02084342 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02013362 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02692079 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02723552 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01928511 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01779713 — Predictive Biomarker (PRD): ACSM3 mRNA
Genes: ACSM3; SAH
Study NCT00315575 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05392478 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03022448 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT04532918 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT03950804 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT03950804 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT03231176 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03231176 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study NCT03231176 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04832217 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03884426 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study NCT03090464 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01610193 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00757484 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02594111 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04250480 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT02871362 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02871362 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00531245 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01864824 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00460447 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT00778986 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01900756 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00164736 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01143792 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01859819 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01308710 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT00126945 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study NCT04665232 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT01244191 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01244191 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01951066 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03915379 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT02604368 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02450136 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT02353741 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02353741 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00435643 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00429247 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00536835 — Predictive Biomarker (PRD): PLK1 mRNA
Genes: PLK1; PLK
Study NCT00012246 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT00012246 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04027309 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT00593658 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05256082 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04747002 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT00434499 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04622956 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00367458 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00367458 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05374928 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT04619537 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT04649983 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04649983 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT02363491 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT03815305 — Safety Biomarker (SAF): Interleukin 1
Study NCT03815305 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT00246870 — Safety Biomarker (SAF): Succinate-semialdehyde dehydrogenase
Genes: ALDH5A1; SSADH
Study NCT00080886 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01754675 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04810585 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT04810585 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04810585 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT04810585 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study NCT03651492 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01937338 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03354377 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01866761 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT01016587 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT03915457 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03729934 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT00395382 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT00395382 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00395382 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00902967 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00902967 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02922192 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02135289 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02135289 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02825654 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00906698 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00906698 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03173586 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02233335 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT04705753 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03615729 — Predictive Biomarker (PRD): RORC mRNA
Genes: RORC; NR1F3; RORG; RZRG
Study NCT01101048 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02483078 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT01243099 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT03956888 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT00727064 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00890162 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03602261 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT03852914 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT00433446 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01940861 — Predictive Biomarker (PRD): SCO2 mRNA
Genes: SCO2
Study NCT02310906 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02781207 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01996891 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01996891 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01996891 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01996891 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00700895 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study NCT01462448 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01462448 — Safety Biomarker (SAF): BDNF
Study NCT00001270 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00001270 — Safety Biomarker (SAF): Interleukin 1
Study NCT01014338 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03862742 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00992186 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT01829217 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01829217 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01829217 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01829217 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT02328105 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study NCT02294006 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02294006 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT02294006 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT02294006 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03410927 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03410927 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT03819127 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00133835 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT01965912 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03414632 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT03852576 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03852576 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03852576 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02536794 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00762294 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00026338 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03609840 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT03609840 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03155477 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02984137 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT02984137 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT02984137 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study NCT01026597 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01235819 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02967887 — Predictive Biomarker (PRD): HMGB2 mRNA
Genes: HMGB2; HMG2
Study NCT00694343 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00743093 — Safety Biomarker (SAF): Acetaminophen-protein adducts
Study NCT05238987 — Predictive Biomarker (PRD): SLC39A14 mRNA
Genes: SLC39A14; KIAA0062; ZIP14
Study NCT05238987 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00003809 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02821559 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT02821559 — Safety Biomarker (SAF): Dihydrothymine dehydrogenase
Genes: DPYD
Study NCT04163640 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study NCT03937258 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT00154466 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00154466 — Predictive Biomarker (PRD): KITLG mRNA
Genes: KITLG; MGF; SCF
Study NCT00154466 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00154466 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study NCT03672084 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT02788045 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03938870 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00559715 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01866592 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01866592 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01866592 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03110276 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study NCT01995201 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02896023 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT03537456 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01286649 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT03986268 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02220556 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03838913 — Predictive Biomarker (PRD): GNAS mRNA
Genes: GNAS; GNAS1
Study NCT03838913 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03838913 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT03838913 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CTNNB1 mRNA
Genes: CTNNB1; CTNNB; OK/SW-cl.35; PRO2286
Study NCT03838913 — Predictive Biomarker (PRD): RNF43 mRNA
Genes: RNF43
Study NCT00562328 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01766284 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01939392 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02298491 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02639533 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02639533 — Safety Biomarker (SAF): BDNF
Study NCT02639533 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00088153 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04541654 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT02129556 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00474344 — Predictive Biomarker (PRD): CASP10 mRNA
Genes: CASP10; MCH4
Study NCT01910532 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04145271 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02827162 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03182712 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04776772 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT00689143 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00093028 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT02319382 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT01935804 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03940131 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04546724 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02535078 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01044199 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01957709 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04142749 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT04203355 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT03555383 — Predictive Biomarker (PRD): HRC mRNA
Genes: HRC; HCP
Study NCT02574858 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02871544 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02871544 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT01848808 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01989273 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00003090 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02937922 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04494464 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT04494464 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01033071 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01074580 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03120637 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT03120637 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT00492037 — Surrogate Endpoint (SUR): Serum sodium